Press Releases and Product Information for August 18, 2021
advertisement
- FDA approves Lyumjev® (insulin lispro-aabc injection) 100 units/mL for use in insulin pumps
- Insulet Announces FDA Clearance of Lyumjev® Rapid-Acting Insulin for Use with Omnipod® Products in the United States
- Matthew Hornberger Named Chief Executive Officer at Association of Diabetes Care & Education Specialists
- CVS Replaces Lantus® With Basaglar® Biosimilar